FNDC3A can be used as a prognostic marker for colorectal cancer and is highly expressed in colon cancer tissues, and high expression of FNDC3A increases the mortality rate of colon cancer patients (Meyer et al., 2012; Wuensch et al., 2019). Here, FNDC3A is linked to colorectal cancer.